Cargando…

Coronavirus disease 2019 and lung cancer: where are we?

Oncology patients are more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to hospital contact and an immunological system that can be compromised by antineoplastic therapy and supportive treatments. Certain similarities have been described in the physiopath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ocanto, Abrahams, Mielgo-Rubio, Xabier, Luna Tirado, Javier, Linares Mesa, Nuria, López Valcárcel, Marta, Pedraza, Sara, Barragan, Victoria Vera, Nieto, Patricia Valencia, Martín, Juan Zafra, Couñago, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration Publishing 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651354/ https://www.ncbi.nlm.nih.gov/pubmed/38023992 http://dx.doi.org/10.37349/etat.2023.00182

Ejemplares similares

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
por: Sereno, María, et al.
Publicado: (2021)

Women in neuroscience: Where are we in 2019?
por: Machlovi, Saima, et al.
Publicado: (2020)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: D’Elia, Emilia, et al.
Publicado: (2020)

Editorial: Neonatal ECMO in 2019: Where Are We Now? Where Next?
por: Cavallaro, Giacomo, et al.
Publicado: (2022)

2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2020)

Tissue engineering of the urethra: where are we in 2019?
por: Chapple, Christopher
Publicado: (2019)

New perspectives in the management of small cell lung cancer
por: Pangua, Cristina, et al.
Publicado: (2022)

Correction to: 2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2020)

Correction: 2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2022)

Correction: 2019 Novel coronavirus: where we are and what we know
por: Cheng, Zhangkai J., et al.
Publicado: (2023)

Nuclear‐medicine probes: Where we are and where we are going
por: Gonzalez‐Montoro, Andrea, et al.
Publicado: (2022)

Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
por: Aguado, Carlos, et al.
Publicado: (2022)

Correction to: Tissue engineering of the urethra: where are we in 2019?
por: Chapple, Christopher
Publicado: (2019)

Alopecia Areata in Latin America: Where are We and Where are We Going?
por: Velásquez-Lopera, Margarita M., et al.
Publicado: (2022)

Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies
por: Martin, Margarita, et al.
Publicado: (2022)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story
por: Serrano, Javier, et al.
Publicado: (2021)

Tsunami of immunotherapy reaches mesothelioma
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2022)

Advances and controversies in the management of early stage non-small cell lung cancer
por: Cilleruelo-Ramos, Angel, et al.
Publicado: (2021)

Computational methods applied to syphilis: where are we, and where are we going?
por: Albuquerque, Gabriela, et al.
Publicado: (2023)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
por: Olmedo, Maria Eugenia, et al.
Publicado: (2022)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

COVID-19: Where We Are, Where We Need to Be
por: Bender Ignacio, Rachel A., et al.
Publicado: (2022)

Where We Are and Where We Are Going in Nut Research
por: Salas-Salvadó, Jordi, et al.
Publicado: (2023)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0r4388haljfudvksk3j28tcp7v